MedTrace Logo

Distress, Anxiety and Psychosexual Health in BOT

NCT04253327 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2026-05-04

No results posted yet for this study

Summary

The aim of this study is to assess the prevalence of distress, anxiety and psychosexual anguish in patients diagnosed with borderline ovarian tumor (BOT) compared to controls confronted with surgical treatment for benign ovarian tumors.

Conditions

  • Ovarian Neoplasm Epithelial Borderline

Interventions

OTHER

questionnaire

Patients will be contacted by their physician during regular follow-up in the out-patient clinic or contacted by phone. The questionnaires will be filled in at the UZBrussel, Laarbeeklaan 101, 1090 Brussels or at the patients home. Filled-in questionnaires can be hand off immediately at the physician or send by post or email..

Sponsors & Collaborators

  • Universitair Ziekenhuis Brussel

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-09-01
Primary Completion
2024-02-01
Completion
2024-05-01

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04253327 on ClinicalTrials.gov